HUP0301233A2 - Készítmények és eljárások a nyálkahártya felületének kezelésére - Google Patents

Készítmények és eljárások a nyálkahártya felületének kezelésére

Info

Publication number
HUP0301233A2
HUP0301233A2 HU0301233A HUP0301233A HUP0301233A2 HU P0301233 A2 HUP0301233 A2 HU P0301233A2 HU 0301233 A HU0301233 A HU 0301233A HU P0301233 A HUP0301233 A HU P0301233A HU P0301233 A2 HUP0301233 A2 HU P0301233A2
Authority
HU
Hungary
Prior art keywords
mucosal surface
amines
compositions
treating
methods
Prior art date
Application number
HU0301233A
Other languages
English (en)
Inventor
John C. Hedenstrom
Michael J. Jozwiakowski
Mark Martinez
Kenneth R. Phares
Kenneth F. Trofatter
Original Assignee
3M Innovative Properties Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/676,339 external-priority patent/US6486168B1/en
Application filed by 3M Innovative Properties Company filed Critical 3M Innovative Properties Company
Publication of HUP0301233A2 publication Critical patent/HUP0301233A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Abstract

A találmány tárgya nyálkahártya-felülettel összefüggő állapotkezelésére szolgáló készítmény, amely a következőket tartalmazza: egyimmunválasz-módosító (IRM) vegyület az imidazokinolin-aminok, azimidazopiridin-aminok, a 6,7-kondenzált cikloalkil-imidazopiridin-aminok, az 1,2-áthidalt imidazokinolin-aminok és azok gyógyászatilagelfogadható sói közül és egy beadásra szolgáló eszköz az IRM-vegyületnyálkahártyafelületre történő felvitelére. Ó
HU0301233A 2000-06-22 2001-06-22 Készítmények és eljárások a nyálkahártya felületének kezelésére HUP0301233A2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21342000P 2000-06-22 2000-06-22
US09/676,339 US6486168B1 (en) 1999-01-08 2000-09-29 Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
PCT/US2001/019979 WO2001097795A2 (en) 2000-06-22 2001-06-22 Systems and methods for treating a mucosal surface

Publications (1)

Publication Number Publication Date
HUP0301233A2 true HUP0301233A2 (hu) 2003-08-28

Family

ID=26908067

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301233A HUP0301233A2 (hu) 2000-06-22 2001-06-22 Készítmények és eljárások a nyálkahártya felületének kezelésére

Country Status (17)

Country Link
EP (1) EP1296644A2 (hu)
JP (1) JP2004508851A (hu)
CN (1) CN1273110C (hu)
AU (1) AU2001270081A1 (hu)
BR (1) BR0112386A (hu)
CA (1) CA2410208A1 (hu)
CZ (1) CZ20024175A3 (hu)
EE (1) EE200200705A (hu)
HR (1) HRP20021024A2 (hu)
HU (1) HUP0301233A2 (hu)
IL (1) IL153087A0 (hu)
MX (1) MXPA02012524A (hu)
NO (1) NO20026067L (hu)
NZ (1) NZ523073A (hu)
PL (1) PL361975A1 (hu)
SK (1) SK17812002A3 (hu)
WO (1) WO2001097795A2 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0211649D0 (en) 2002-05-21 2002-07-03 Novartis Ag Organic compounds
CA2502696A1 (en) 2002-10-21 2004-05-06 Mgi Pharma Biologics, Inc. Compositions and methods for treating human papillomavirus-mediated disease
AU2004284927A1 (en) * 2003-10-22 2005-05-12 University Hospitals Of Cleveland Method and apparatus for applying medication to internal tissue
EP1844201B1 (en) 2005-02-04 2016-08-24 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
EP1140091B1 (en) * 1999-01-08 2005-09-21 3M Innovative Properties Company Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia

Also Published As

Publication number Publication date
EE200200705A (et) 2004-08-16
CA2410208A1 (en) 2001-12-27
WO2001097795A3 (en) 2002-04-04
NO20026067D0 (no) 2002-12-17
WO2001097795A2 (en) 2001-12-27
MXPA02012524A (es) 2003-04-10
PL361975A1 (en) 2004-10-18
CZ20024175A3 (cs) 2003-06-18
CN1437463A (zh) 2003-08-20
NZ523073A (en) 2005-04-29
IL153087A0 (en) 2003-06-24
BR0112386A (pt) 2003-06-10
CN1273110C (zh) 2006-09-06
AU2001270081A1 (en) 2002-01-02
HRP20021024A2 (en) 2005-02-28
EP1296644A2 (en) 2003-04-02
NO20026067L (no) 2003-02-17
SK17812002A3 (sk) 2003-05-02
JP2004508851A (ja) 2004-03-25

Similar Documents

Publication Publication Date Title
NO20013230L (no) Preparater og fremgangsmater for behandling av slimhinneassosierte tilstander med en immunreaksjonsmodifiserende forbindelse
HUP0101543A2 (hu) Női szexuális zavarok kezelésére szolgáló gyógyszerkészítmények
JP2005519849A5 (hu)
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
HUT77667A (hu) Imidazo[4,5-c]kinolin-aminok, ezeket tartalmazó gyógyászati készítmények, és alkalmazásuk
NO991908D0 (no) Forbindelser som modifiserer immunresponsen til behandling av TH-2 medierte og beslektede sykdommer
HUP0102728A2 (hu) Módszerek és transzdermális készítmények fájdalom csillapítására
DE60327438D1 (de) Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen
ATE261444T1 (de) Pyrazolopyridine
HUP0302475A2 (hu) Eljárás allergia kezelésére szubsztituált pirazolok alkalmazásával
HUP0203028A2 (hu) Tolterodint tartalmazó gyógyszerkészítmény és alkalmazása
JP2008526752A5 (hu)
HU0102272D0 (en) Compositions and methods for stimulating gastrointestinal motilis
MA27566A1 (fr) Inhibiteurs de 4-oxo-1-(3-phenyle substitue -1, 4-dihydro-1, 8-naphthyridine-3-carboxamide phosphodiesterase-4
HUP0400200A2 (hu) Gyógyászati készítmény apomorfin, 6aR-(-)-N-propil-norapomorfin és származékai, valamint prodrugjai hatékony adagolására
WO2003077857A3 (en) N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
HUP0301233A2 (hu) Készítmények és eljárások a nyálkahártya felületének kezelésére
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
HUP0402358A2 (hu) Szelektív dopamin D4 receptor agonisták alkalmazása szexuális diszfunkciók kezelésére alkalmas gyógyszerkészítmény előállítására
GB0319037D0 (en) 7-Azaindole Derivatives
MX2022003095A (es) Tratamiento de cancer mediante una combinacion que comprende un inhibidor de la multi-tirosina quinasa y un inhibidor de puntos de control inmunitarios.
MX2020007494A (es) Formulaciones orales de metronidazol y metodos de tratamiento de una infeccion con las mismas.
HUP0303181A2 (hu) 4-Foszfodiészteráz típusú inhibitorok alkalmazása miokardiális betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
HUP0300313A2 (hu) Vegyület, ezt tartalmazó gyógyszerkészítmény és alkalmazása fájdalom kezelésére
HUP0300043A2 (en) Method and composition for the treatment of pain

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP

Free format text: FORMER OWNER(S): 3M INNOVATIVE PROPERTIES COMPANY, US

FD9A Lapse of provisional protection due to non-payment of fees